$6.65
0.60% day before yesterday
NYSE, Nov 07, 10:00 pm CET
ISIN
CA0717341071
Symbol
BHC

Bausch Health Companies Inc. Stock price

$6.65
+0.26 4.07% 1M
+1.95 41.49% 6M
-1.41 17.49% YTD
-2.77 29.41% 1Y
-0.74 10.01% 3Y
-12.51 65.29% 5Y
-78.76 92.21% 10Y
-17.76 72.75% 20Y
NYSE, Closing price Fri, Nov 07 2025
-0.04 0.60%
ISIN
CA0717341071
Symbol
BHC
Industry

Key metrics

Basic
Market capitalization
$2.5b
Enterprise Value
$22.2b
Net debt
$19.7b
Cash
$1.3b
Shares outstanding
370.5m
Valuation (TTM | estimate)
P/E
6.9 | 1.7
P/S
0.2 | 0.2
EV/Sales
2.2 | 2.2
EV/FCF
20.5
P/B
negative
Financial Health
Equity Ratio
-4.8%
Return on Equity
3.6%
ROCE
9.4%
ROIC
5.2%
Debt/Equity
-37.2
Financials (TTM | estimate)
Revenue
$10.0b | $10.3b
EBITDA
$3.1b | $3.5b
EBIT
$2.1b | $3.2b
Net Income
$362.0m | $1.5b
Free Cash Flow
$1.1b
Growth (TTM | estimate)
Revenue
5.9% | 6.8%
EBITDA
8.7% | 18.5%
EBIT
18.6% | 74.3%
Net Income
303.4% | 3,309.0%
Free Cash Flow
7.4%
Margin (TTM | estimate)
Gross
70.7%
EBITDA
30.9% | 33.8%
EBIT
20.7%
Net
3.6% | 14.4%
Free Cash Flow
10.8%
More
EPS
$1.0
FCF per Share
$2.9
Short interest
2.2%
Employees
21k
Rev per Employee
$460.0k
Show more

Is Bausch Health Companies Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,024 stocks worldwide.

Bausch Health Companies Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Bausch Health Companies Inc. forecast:

5x Hold
56%
4x Sell
44%

Analyst Opinions

9 Analysts have issued a Bausch Health Companies Inc. forecast:

Hold
56%
Sell
44%

Financial data from Bausch Health Companies Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
10,029 10,029
6% 6%
100%
- Direct Costs 2,942 2,942
7% 7%
29%
7,087 7,087
6% 6%
71%
- Selling and Administrative Expenses 3,376 3,376
4% 4%
34%
- Research and Development Expense 631 631
4% 4%
6%
3,098 3,098
9% 9%
31%
- Depreciation and Amortization 1,024 1,024
7% 7%
10%
EBIT (Operating Income) EBIT 2,074 2,074
19% 19%
21%
Net Profit 362 362
303% 303%
4%

In millions USD.

Don't miss a Thing! We will send you all news about Bausch Health Companies Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Bausch Health Companies Inc. Stock News

Neutral
Accesswire
4 days ago
Expansion improves access to treatment options within periodontal care and helps strengthen partnerships with dental professionals within these populations. LAVAL, QC / ACCESS Newswire / November 5, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global diversified pharmaceutical company, and OraPharma, its dental products business, today announced the commercial expansion of OraPhar...
Neutral
Business Wire
6 days ago
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will hold an investor day on Thursday, Nov. 13, 2025, at the New York Stock Exchange. Chairman and CEO Brent Saunders will provide an update on the company's transformation and strategic outlook, and Executive Vice President an...
Positive
Seeking Alpha
9 days ago
Bausch Health Companies delivered strong Q3 results, with revenue up 6.8% year-over-year and EPS beating estimates by $0.10. BHC's growth is driven by successful product launches like Cabtreo, robust Xifaxan performance, and expansion in dermatology and aesthetics segments. The company raised guidance on adjusted EBITDA and operating cash flow, supported by cost management and strategic investm...
More Bausch Health Companies Inc. News

Company Profile

Manufactures and markets pharmaceutical products

Head office Canada
CEO Thomas Appio
Employees 20,700
Founded 1994
Website www.bauschhealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today